Key clinical point: ARMSS-rate at 2 years accurately predicts disease course over the subsequent 8 years.
Major finding: ARMSS-rate at 2 years had an area under the curve of 0.921 for predicting the next 8 years of ARMSS-rate.
Study details: An analysis of data for 4,514 participants in the Swedish MS Registry.
Disclosures: Dr. Ramanujam had no conflicts of interest to disclose. He receives funding from the MultipleMS Project, which is part of the EU Horizon 2020 Framework.